Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression.
Sun Y, Chen J, Hong JH, Xiao R, Teng Y, Wang P, Deng P, Yu Z, Chan JY, Chai KXY, Gao J, Wang Y, Pan L, Liu L, Liu S, Teh BT, Yu Q, Lim ST, Li W, Xu B, Ong CK, Tan J.
Sun Y, et al. Among authors: pan l.
Oncogene. 2024 May 23. doi: 10.1038/s41388-024-03065-6. Online ahead of print.
Oncogene. 2024.
PMID: 38783101